Xiaoman Jiang

Title: Xiaoman Jiang: Innovator in Sustained-Release Drug Delivery

Introduction

Xiaoman Jiang is a notable inventor based in Zhuhai, China. He has made significant contributions to the field of pharmaceutical technology, particularly in drug delivery systems. His innovative work focuses on the development of sustained-release formulations that enhance the efficacy of medications.

Latest Patents

Xiaoman Jiang holds a patent for an "Aripiprazole sustained-release microsphere and preparation method therefor." This invention provides a novel microsphere formulation that comprises aripiprazole and polylactide-glycolide. The microsphere features a spherical reticular skeleton structure with reticular micropores distributed across its surface, allowing for the encapsulation of aripiprazole within these micropores. The average particle diameter of the microsphere is less than 20 μm, making it suitable for administration through a 5 gauge needle. The content of aripiprazole in the microsphere ranges from 65% to 80% of its total weight, ensuring effective drug delivery.

Career Highlights

Xiaoman Jiang is currently associated with Zhuhai Livzon Microsphere Technology Co. Ltd., where he continues to advance his research in drug delivery systems. His work has garnered attention for its potential to improve patient outcomes through innovative pharmaceutical formulations.

Collaborations

Xiaoman collaborates with several talented individuals in his field, including Bin Chen and Xia Yin, who contribute to the research and development efforts at their company.

Conclusion

Xiaoman Jiang's contributions to the field of sustained-release drug delivery exemplify the impact of innovative thinking in pharmaceuticals. His patent on aripiprazole microspheres showcases his commitment to enhancing medication efficacy and patient care.